Pauline Akoo

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach et al. · Human Vaccines & Immunotherapeutics · 2019 · 66 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast

David Tiga Kangoye, Abdisalan M. Noor, Janet Midega et al. · Malaria Journal · 2016 · 56 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

Lucas Otieno, Yolanda Guerra Mendoza, Samuel Adjei et al. · Vaccine · 2019 · 22 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17